Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol
Keyword(s):
Phase 2
◽
2015 ◽
Vol 93
(4)
◽
pp. 757-764
◽